The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.

Michal EiferGregory Peters-FounshteinLotem Cohn YoelHodaya PinianRoee SteinerEyal KlangOnofrio A CatalanoYael EshetLiran Domachevsky

Published in: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology (2024)

Our findings highlight the potential of FDG PET/CT radiomic features as a predictor for the response to neoadjuvant therapy in esophageal cancer patients. The combination of these radiomic features with select non-radiomic variables provides a model for stratifying patients based on their likelihood to respond to neoadjuvant treatment.

Keyphrases

rectal cancer
lymph node
locally advanced
ejection fraction
newly diagnosed
prognostic factors
squamous cell carcinoma
radiation therapy
combination therapy
magnetic resonance
climate change
risk assessment
patient reported outcomes